Safe Sea SPF 40 Spray 40z

Safe Sea

$ 18.00 

SPF 40 formula is available in a 4 oz. lotion or manual pump spray. 1 oz. provides approximately one full-body adult application. Both provide protection against jellyfish stings and are hypoallergenic, biodegradable, and harmless to aquatic life.

About the product

  • Prevent the stings from most jellyfish and sea lice.
  • Gives you sun rays and UV protection
  • Scientifically proven formula
  • Dermatologically tested and waterproof
  • Bottle is biodegradable and non-toxic for the marine environment

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

 Ingredients

Inactive Ingredients: Aqua, Cyclopentasiloxane, Stearyl Dimethicone, Cetyl Dimethicone, Propylene Glycol, Lauryl PEG / PPG — 18/18 Methicone, Cetyl PEG/PPG-10/1 Dimethicone, Hydrogenated Castor Oil, Panthenol, Tocopheryl Acetate, Lanthanum Chloride, Magnesium Chloride, Calcium Chloride, Plankton Extract, Glycoproteins, Glycosaminoglycans, Benzyl Alcohol, Fragrance, Chlorphenesin, Benzoic Acid, Sorbic Acid, Dehydroacetic Acid, Tetrasodium EDTA, Sodium Citrate, Triethoxycaprylylsilane,Trimethoxycaprylylsilane.


Active Ingredients:

Octinoxate 7.5 % Octisalate 5 % Zinc Oxide 5 % Titanium Dioxide 2 %

DIRECTIONS:

Apply liberally 15 minutes before sun exposure and reapply After 80 minutes of swimming or sweating, immediately after towel drying and at least every 2 hours.

Other Information:

Give particular attention to coverage of arms and legs. In water infested by Sea Lice or Jellyfish, Safe Sea should also be applied under the bathing suit. Jellyfish can be dangerous. This product should not be considered a recommendation to go into jellyfish infested water, nor is it a guarantee against stings. In case of sting do not use Safe Sea as a treatment seek medical attention. Tested against Sea nettle ( Chrysaora ) Atlantic Box jellyfish (Chiropsalmus ) and Rhopilema.

Newsletter